Close Menu

Women who carry BRCA1 or 2 mutations and who had mastectomies or salpingo-oophorectomies were found to have a decreased risk of developing breast or ovarian cancer, researchers report in the Journal of the American Medical Association. The researchers, led by the University of Pennsylvania School of Medicine's Timothy Rebbeck followed 2,482 women with BRCA1 or BRCA2 mutations, some of whom then had mastectomies or salpingo-oophorectomies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.